Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

about

Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation.Diabetic retinopathy and pregnancy.

P2860

Q33729704-222492CF-6A54-465F-95AB-4642E7AC049C Q38183797-C3DAEF3E-7266-4A86-A401-17192C1163D7

P2860

Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

Item

http://www.wikidata.org/entity/Q47313045

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

@en

Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

@nl

type

Item

label

Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

@en

Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

@nl

prefLabel

Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

@en

Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

@nl

P1476

Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

@en

P2093

Hiilesmaa V

http://www.w3.org/2001/XMLSchema#string

Immonen I

http://www.w3.org/2001/XMLSchema#string

Kaaja RJ

http://www.w3.org/2001/XMLSchema#string

Koistinen R

http://www.w3.org/2001/XMLSchema#string

Laatikainen L

http://www.w3.org/2001/XMLSchema#string

Loukovaara S

http://www.w3.org/2001/XMLSchema#string

Rudge J

http://www.w3.org/2001/XMLSchema#string

Teramo KA

http://www.w3.org/2001/XMLSchema#string

P2860

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

Angiogenesis in cancer, vascular, rheumatoid and other disease

Vascular-specific growth factors and blood vessel formation

The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

P304

697-704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-5491.2004.01235.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15209761

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

gestational diabetes

Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

about

P2860

P2860

Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921